Proxima Ventures Ltd logo

Proxima Ventures Ltd

Asia, Tel Aviv, Israel, Tel Aviv

Description

Proxima Investments specializes in the management of investment portfolios for a variety of clients in Israel and abroad.

Investor Profile

Proxima Ventures Ltd has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Israel, China.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Seed (43%)
  • Series B (29%)
  • Series Unknown (14%)
  • Series A (14%)

Country Focus

  • United States (43%)
  • Israel (29%)
  • China (14%)
  • France (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Oncology
  • Cloud Computing
  • Ios
  • Mobile Devices
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Proxima Ventures Ltd frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 3
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
CL
Asia, Beijing, China, Beijing
Co-Investments: 1
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Giza Venture Capital
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Mana Ventures
North America, California, United States, San Francisco
Co-Investments: 3
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

Which angels does Proxima Ventures Ltd often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Proxima Ventures Ltd?

VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 23, 2024
Amount Raised: $4,500,000
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 20, 2023
Amount Raised: $3,125,000
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedJul 27, 2022
Amount Raised: $2,500,000
Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
HiFiBiO

Paris, Ile-de-France, France

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BMay 16, 2018
Amount Raised: $37,500,000
Soluto

Tel Aviv, Tel Aviv, Israel

Soluto is an all-in-one support and digital protection service that enables users to contact premier support technicians.

Cloud ComputingiOSMobile Devices
Series BJun 23, 2011
Amount Raised: $10,200,000
Soluto

Tel Aviv, Tel Aviv, Israel

Soluto is an all-in-one support and digital protection service that enables users to contact premier support technicians.

Cloud ComputingiOSMobile Devices
Series ANov 3, 2009
Amount Raised: $6,200,000

Find More Investors Like Proxima Ventures Ltd

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Proxima Ventures Ltd | Pipeseed